1. Home
  2. APRE vs BNAI Comparison

APRE vs BNAI Comparison

Compare APRE & BNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • BNAI
  • Stock Information
  • Founded
  • APRE 2006
  • BNAI 2018
  • Country
  • APRE United States
  • BNAI United States
  • Employees
  • APRE N/A
  • BNAI N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • BNAI
  • Sector
  • APRE Health Care
  • BNAI
  • Exchange
  • APRE Nasdaq
  • BNAI NYSE
  • Market Cap
  • APRE 13.5M
  • BNAI 15.7M
  • IPO Year
  • APRE 2019
  • BNAI N/A
  • Fundamental
  • Price
  • APRE $1.80
  • BNAI $0.32
  • Analyst Decision
  • APRE Strong Buy
  • BNAI Strong Buy
  • Analyst Count
  • APRE 2
  • BNAI 1
  • Target Price
  • APRE $15.50
  • BNAI $6.00
  • AVG Volume (30 Days)
  • APRE 21.0K
  • BNAI 358.4K
  • Earning Date
  • APRE 05-13-2025
  • BNAI 05-25-2025
  • Dividend Yield
  • APRE N/A
  • BNAI N/A
  • EPS Growth
  • APRE N/A
  • BNAI N/A
  • EPS
  • APRE N/A
  • BNAI N/A
  • Revenue
  • APRE $1,502,581.00
  • BNAI $99,790.00
  • Revenue This Year
  • APRE N/A
  • BNAI $189.69
  • Revenue Next Year
  • APRE N/A
  • BNAI $2,400.00
  • P/E Ratio
  • APRE N/A
  • BNAI N/A
  • Revenue Growth
  • APRE 157.63
  • BNAI 125.10
  • 52 Week Low
  • APRE $1.85
  • BNAI $0.30
  • 52 Week High
  • APRE $6.70
  • BNAI $8.43
  • Technical
  • Relative Strength Index (RSI)
  • APRE 26.70
  • BNAI 31.82
  • Support Level
  • APRE $1.85
  • BNAI $0.36
  • Resistance Level
  • APRE $2.30
  • BNAI $0.40
  • Average True Range (ATR)
  • APRE 0.16
  • BNAI 0.03
  • MACD
  • APRE -0.01
  • BNAI 0.00
  • Stochastic Oscillator
  • APRE 2.50
  • BNAI 5.24

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About BNAI BRAND ENGAGEMENT NETWORK INC

Brand Engagement Network Inc is an innovative AI platform provider, designed to interface with emerging technologies, including blockchain, the Internet of Things, and cloud computing, that drive digital transformation across various industries and provide businesses with an unparalleled competitive edge. BEN offers a suite of configured and customizable applications, including natural language processing, anomaly detection, encryption, recommendation engines, sentiment analysis, image recognition, personalization, and real-time decision-making.

Share on Social Networks: